Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction

Stopped Due to Negative feasibility assessment of recruiting the planned number of subjects within the study timelines

Conditions

• AMI

Interventions

• DRUG: Insulin Glargine (LANTUS)
• DRUG: Insulin Glulisine (Apidra)
• DRUG: Standard Therapy

Sponsor

Sanofi